Study reveals COPD linked to increased bacterial invasion

April 27, 2016

Chronic obstructive pulmonary disease (COPD) is a common smoking-related lung illness and the third leading cause of death in the United States. Scientists have long believed that inhaling toxic gases and particles from tobacco smoke causes inflammation of the small airways in the lungs, leading to the development of COPD. However, the theory doesn't explain why airway inflammation and disease progression continue even after the patient stops smoking.

Now a study led by Vanderbilt University Medical Center (VUMC) investigators finds that persistent inflammation in COPD may result from a defect in the immune system that allows airway bacteria to invade deeper into the lung. The research led by first author Bradley Richmond, M.D., instructor in the Division of Allergy, Pulmonary and Critical Care, and senior authors Timothy Blackwell, M.D. and Vasiliy Polosukhin, M.D., Ph.D. was published online April 5, 2016 in Nature Communications.

The investigators were interested in the function of the body's mucus membranes like those found in the nose and the lining of the lungs. Mucosal surfaces normally have an elaborate barrier that prevents bacteria from invading into deeper tissues. Having previously shown that patients with COPD often lack a key component of this barrier called secretory immunoglobulin A (secretory IgA), the investigators studied mice lacking secretory IgA. While these mice appeared healthy at birth, as they aged they developed increased bacterial invasion, chronic inflammation, and damage in the lungs similar to patients with COPD. These changes occurred without cigarette smoke or other exposures."These findings suggest that over time changes in the airways resulting from cigarette smoke exposure make the lungs more susceptible to bacterial invasion. This may explain why inflammation persists in COPD even after patients stop smoking," said Richmond.

Treatment with the anti-inflammatory drug roflumilast halted lung damage in secretory IgA-deficient mice, suggesting a possible future therapy for patients with COPD and decreased secretory IgA in small airways.
-end-
The study was funded in part by a two-year grant to Richmond from the American Lung Association. Other investigators include Wei Han, M.D., Rui-Hong Du, M.D., Yongqin Zhang, Ph.D., Dong-Sheng Cheng, Ph.D., Linda Gleaves, Rasul Abdolrasulnia, Ph.D., Dina Polosukhina, M.S., Peter Clark, M.D., Seth Bordenstein, Ph.D., and Vasiliy Polosukhin, M.D., Ph.D., Sc.D., Vanderbilt; Timothy Blackwell, M.D., Vanderbilt and the Department of Veterans Affairs Medical Center, Nashville, Tennessee; and Robert Brucker, Ph.D., Rowland Institute, Cambridge, Massachusetts.

This work was supported by grants from the US National Institutes of Health (NIH NHLBI HL092870, HL085317, HL105479, T32 HL094296, NIH HL088263, NIH HL126176, NIH NCRR UL1 RR024975 and NCI U01 CA152662), the American Lung Association, the National Science Foundation (DEB 1046149), the Department of Veterans Affairs and Forest Research Institute grant (DAL-IT-07).

Vanderbilt University Medical Center

Related Inflammation Articles from Brightsurf:

3D printed stents that treat inflammation
POSTECH Professor Dong-Woo Cho's research team develops bioink-loaded esophageal stents for treating radiation esophagitis.

New cause of inflammation in people with HIV identified
A new study led by researchers at Boston Medical Center examined what factors could be contributing to this inflammation, and they identified the inability to control HIV RNA production from existing HIV DNA as a potential key driver of inflammation.

Maltreatment tied to higher inflammation in girls
New research by a University of Georgia scientist reveals that girls who are maltreated show higher levels of inflammation at an early age than boys who are maltreated or children who have not experienced abuse.

A protein that controls inflammation
A study by the research team of Prof. Geert van Loo (VIB-UGent Center for Inflammation Research) has unraveled a critical molecular mechanism behind autoimmune and inflammatory diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis.

Inflammation in the brain linked to several forms of dementia
Inflammation in the brain may be more widely implicated in dementias than was previously thought, suggests new research from the University of Cambridge.

Social isolation could cause physical inflammation
Social isolation could be associated with increased inflammation in the body new research from the University of Surrey and Brunel University London has found.

Hydrogels control inflammation to help healing
Researchers test a sampling of synthetic, biocompatible hydrogels to see how tuning them influences the body's inflammatory response.

Why beta-blockers cause skin inflammation
Beta-blockers are often used to treat high blood pressure and other cardiovascular diseases.

The 'inflammation' of opioid use
New research correlates inflammation in the brain and gut to negative emotional state during opioid withdrawal.

Using a common anticonvulsant to counteract inflammation
The interaction between a chromosomal protein called HMGB1 and a cellular receptor called RAGE is known to trigger inflammation.

Read More: Inflammation News and Inflammation Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.